Current Rating and Its Significance
MarketsMOJO’s 'Sell' rating for Suraksha Diagnostic Ltd indicates a cautious stance for investors considering this stock. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The rating suggests that, given the present data, the stock may underperform relative to the broader market and peers in the healthcare services sector. Investors should weigh this guidance carefully when making portfolio decisions.
Quality Assessment
As of 09 March 2026, Suraksha Diagnostic Ltd holds a good quality grade. This reflects the company’s operational strengths and business fundamentals, including its service offerings and market positioning within the healthcare services sector. Despite this positive quality assessment, other factors weigh heavily against the stock’s outlook.
Valuation Perspective
The stock’s valuation is currently deemed attractive, signalling that Suraksha Diagnostic Ltd is trading at a price level that could be considered reasonable or undervalued relative to its earnings potential and asset base. This valuation grade suggests that, from a price standpoint, the stock might offer value to investors. However, valuation alone does not guarantee positive returns, especially when other metrics are less favourable.
Financial Trend and Performance
The financial trend for Suraksha Diagnostic Ltd is negative as of today. The latest data shows several concerning indicators: the company reported negative results in December 2025, with operating profit to interest ratio at a quarterly low of 7.33 times, signalling tighter coverage of interest expenses. The debt-equity ratio stood at a relatively high 0.51 times in the half-year period, indicating increased leverage. Interest expenses also peaked at ₹3.16 crores quarterly, adding pressure on profitability.
These financial challenges are reflected in the stock’s returns, which have been disappointing. As of 09 March 2026, Suraksha Diagnostic Ltd has delivered a negative return of -10.13% over the past year. The stock has also underperformed the BSE500 index over the last three years, one year, and three months, highlighting persistent underperformance relative to the broader market.
Technical Analysis
From a technical standpoint, the stock is rated bearish. Recent price movements show a downward trend, with the stock declining by 2.99% on the latest trading day and falling 11.79% over the past month. This negative momentum suggests that market sentiment remains weak, and the stock may face continued selling pressure in the near term.
Summary of Current Stock Returns
Suraksha Diagnostic Ltd’s recent performance metrics as of 09 March 2026 are as follows:
- 1 Day: -2.99%
- 1 Week: -5.33%
- 1 Month: -11.79%
- 3 Months: -9.52%
- 6 Months: -17.81%
- Year-to-Date: -6.23%
- 1 Year: -10.13%
These figures underscore the stock’s recent struggles and reinforce the rationale behind the current 'Sell' rating.
What This Means for Investors
For investors, the 'Sell' rating from MarketsMOJO suggests prudence when considering Suraksha Diagnostic Ltd as part of their portfolio. While the company maintains good quality and attractive valuation metrics, the negative financial trends and bearish technical signals indicate potential risks ahead. Investors should carefully assess their risk tolerance and investment horizon before initiating or maintaining positions in this stock.
Sector and Market Context
Operating within the healthcare services sector, Suraksha Diagnostic Ltd faces competitive pressures and financial headwinds that have impacted its recent performance. The microcap status of the company also implies higher volatility and liquidity considerations compared to larger peers. These factors contribute to the cautious stance reflected in the current rating.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
Conclusion
Suraksha Diagnostic Ltd’s current 'Sell' rating by MarketsMOJO, last updated on 05 February 2026, reflects a comprehensive evaluation of the company’s present fundamentals and market conditions as of 09 March 2026. Despite a good quality grade and attractive valuation, the negative financial trends and bearish technical outlook weigh heavily on the stock’s prospects. Investors should consider these factors carefully and monitor ongoing developments before making investment decisions.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
